CASI PHARMACEUTICALS, INC. Depreciation
CASI PHARMACEUTICALS, INC. (CASIF) reported Depreciation of $1.23 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-05-15
| Period end | Depreciation 12 month |
|---|---|
| 2025-12-31 | $1.23M 20-F · filed 2026-05-15 |
| 2024-12-31 | $1.27M 20-F · filed 2026-05-15 |
| 2023-12-31 | $2.45M 20-F · filed 2026-05-15 |
| 2022-12-31 | $1.21M 20-F · filed 2025-03-31 |